Powering healthcare’s digital transformation.

Latest news

10-year anniversary of KDA Group Inc. listing on TSXV

January 2025. It is with great excitement and pride that we share with you a photo of the outdoor display at the Market Center in downtown Toronto to celebrate the 10-year anniversary of KDA Group Inc.’s listing on TSXV.  See picture

Adherize+ platform update

March 2024. The KDA Group is pleased to announce an update in the development and use of its Adherize+ platform. With the aim of assisting and improving the follow-up of hormone-dependent breast cancer patients taking oral CDK 4/6 inhibitor therapy, the Corporation, through its Adherize+ platform, will develop the monitoring and follow-up algorithm for these patients in collaboration with oncology physicians and pharmacists.

Collaboration with several pharmacy banners

March 2024. The KDA Group is proud to announce that it is working with several Quebec and Canadian pharmacy banners to ensure the performance of its pharmacological adherence software, Adherize+.

Careers

Join an experienced international team pioneering the development of ground-breaking solutions that are transforming global healthcare systems.